Compare Novartis with KEMP & CO - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs KEMP & CO - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS KEMP & CO NOVARTIS/
KEMP & CO
 
P/E (TTM) x 88.8 -131.6 - View Chart
P/BV x 2.8 0.6 437.9% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 NOVARTIS   KEMP & CO
EQUITY SHARE DATA
    NOVARTIS
Mar-21
KEMP & CO
Mar-21
NOVARTIS/
KEMP & CO
5-Yr Chart
Click to enlarge
High Rs770475 162.1%   
Low Rs501333 150.3%   
Sales per share (Unadj.) Rs154.521.6 716.2%  
Earnings per share (Unadj.) Rs8.5-5.7 -147.5%  
Cash flow per share (Unadj.) Rs13.4-3.4 -397.3%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.21,321.0 21.9%  
Shares outstanding (eoy) m24.691.08 2,286.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.118.7 21.9%   
Avg P/E ratio x75.1-70.4 -106.6%  
P/CF ratio (eoy) x47.5-120.1 -39.5%  
Price / Book Value ratio x2.20.3 718.0%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,691437 3,594.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0858 12,780.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,81423 16,374.0%  
Other income Rs m3321 47,428.6%   
Total revenues Rs m4,14624 17,287.3%   
Gross profit Rs m267-5 -5,411.8%  
Depreciation Rs m1223 4,731.5%   
Interest Rs m770-   
Profit before tax Rs m400-7 -5,888.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m191-1 -31,900.0%   
Profit after tax Rs m209-6 -3,371.0%  
Gross profit margin %7.0-21.2 -33.0%  
Effective tax rate %47.88.9 540.0%   
Net profit margin %5.5-26.6 -20.6%  
BALANCE SHEET DATA
Current assets Rs m9,22431 29,581.5%   
Current liabilities Rs m3,5738 45,685.4%   
Net working cap to sales %148.2100.3 147.7%  
Current ratio x2.64.0 64.8%  
Inventory Days Days17622,286 0.8%  
Debtors Days Days37206,165 0.0%  
Net fixed assets Rs m2,4801,438 172.5%   
Share capital Rs m12311 1,142.6%   
"Free" reserves Rs m7,0181,416 495.7%   
Net worth Rs m7,1411,427 500.6%   
Long term debt Rs m00-   
Total assets Rs m11,7031,469 796.8%  
Interest coverage x6.2NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.30 2,055.0%   
Return on assets %2.4-0.4 -578.4%  
Return on equity %2.9-0.4 -673.3%  
Return on capital %6.7-0.5 -1,401.3%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-692-7 10,407.5%  
From Investments Rs m952-3 -31,098.0%  
From Financial Activity Rs m-368-1 68,148.1%  
Net Cashflow Rs m-109-10 1,058.5%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 73.4 0.0 -  
Indian inst/Mut Fund % 1.3 0.1 957.1%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.6 28.5 93.4%  
Shareholders   44,652 788 5,666.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   TRANS ASIA CORP  SIMPLEX PAPERS  OLYMPIC OIL  VERITAS  SIRCA PAINTS INDIA  



Today's Market

Sensex Ends Above 60,000-Mark, Nifty Tops 17,850; Asian Paints & Eicher Motors Climb 3%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

A Great Time to Buy ITC(Profit Hunter)

Sep 17, 2021

Is the worst over for the stock of ITC?

Top Small Caps to Buy Now(Views On News)

Sep 18, 2021

Rahul Shah on why he would invest in these unusual 20 small cap stocks

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Sep 24, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - QUASAR INDIA COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS